Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gregson

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
European Heart Journal|October 15, 2024
The win ratio in cardiology trials: lessons learnt, new developments, and wise future useStuart J Pocock, John Gregson, Timothy J Collier, et al.
BMJ Open|January 14, 2021
Is night-time light intensity associated with cardiovascular disease risk factors among adults in early-stage urbanisation in South India? A cross-sectional study of the Andhra Pradesh Children and Parents StudyTina Bonde Sorensen, Robin Wilson, John Gregson, et al.
BMC Infectious Diseases|January 25, 2024
A retrospective analysis of 20,178 adult neurological infection admissions to United Kingdom critical care units from 2001 to 2020Joseph Donovan, Abena Glover, John Gregson, et al.
Journal of Hypertension|September 1, 2017
Individualizing treatment choices in the systolic blood pressure intervention trialJoão Pedro Ferreira, John Gregson, Kévin Duarte, et al.
Heart (British Cardiac Society)|August 10, 2016
International patterns of dual antiplatelet therapy duration after acute coronary syndromesHéctor Bueno, Stuart Pocock, Nicolas Danchin, et al.
The Lancet. Healthy Longevity|September 13, 2022
Blood cholesterol and risk of dementia in more than 1·8 million people over two decades: a retrospective cohort studyMasao Iwagami, Nawab Qizilbash, John Gregson, et al.
Plos One|April 2, 2020
Is agricultural engagement associated with lower incidence or prevalence of cardiovascular diseases and cardiovascular disease risk factors? A systematic review of observational studies from low- and middle-income countriesTina B Sørensen, Mika Matsuzaki, John Gregson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2018
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort studyJoão Pedro Ferreira, Cécile Couchoud, John Gregson, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 28, 2021
Long Term Restenosis Rate After Carotid Endarterectomy: Comparison of Three Surgical Techniques and Intra-Operative Shunt UseSuk F Cheng, Toby Richards, John Gregson, et al.
European Heart Journal|September 9, 2020
The win ratio approach for composite endpoints: practical guidance based on previous experienceBjörn Redfors, John Gregson, Aaron Crowley, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
European Heart Journal|October 15, 2024
The win ratio in cardiology trials: lessons learnt, new developments, and wise future useStuart J Pocock, John Gregson, Timothy J Collier, et al.
BMJ Open|January 14, 2021
Is night-time light intensity associated with cardiovascular disease risk factors among adults in early-stage urbanisation in South India? A cross-sectional study of the Andhra Pradesh Children and Parents StudyTina Bonde Sorensen, Robin Wilson, John Gregson, et al.
BMC Infectious Diseases|January 25, 2024
A retrospective analysis of 20,178 adult neurological infection admissions to United Kingdom critical care units from 2001 to 2020Joseph Donovan, Abena Glover, John Gregson, et al.
Journal of Hypertension|September 1, 2017
Individualizing treatment choices in the systolic blood pressure intervention trialJoão Pedro Ferreira, John Gregson, Kévin Duarte, et al.
Heart (British Cardiac Society)|August 10, 2016
International patterns of dual antiplatelet therapy duration after acute coronary syndromesHéctor Bueno, Stuart Pocock, Nicolas Danchin, et al.
The Lancet. Healthy Longevity|September 13, 2022
Blood cholesterol and risk of dementia in more than 1·8 million people over two decades: a retrospective cohort studyMasao Iwagami, Nawab Qizilbash, John Gregson, et al.
Plos One|April 2, 2020
Is agricultural engagement associated with lower incidence or prevalence of cardiovascular diseases and cardiovascular disease risk factors? A systematic review of observational studies from low- and middle-income countriesTina B Sørensen, Mika Matsuzaki, John Gregson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2018
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort studyJoão Pedro Ferreira, Cécile Couchoud, John Gregson, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 28, 2021
Long Term Restenosis Rate After Carotid Endarterectomy: Comparison of Three Surgical Techniques and Intra-Operative Shunt UseSuk F Cheng, Toby Richards, John Gregson, et al.
European Heart Journal|September 9, 2020
The win ratio approach for composite endpoints: practical guidance based on previous experienceBjörn Redfors, John Gregson, Aaron Crowley, et al.
Pageof 12